bpc 157 and ms multiple sclerosis clinical trial humans Failed, Inconclusive or Interrupted Trials in Sclerosis: 2020-2024 Update Frontiers The Hidden Risks of BPC‑157:

For selected symptomatic patients please review Figure 1: B 12 Test Result Review and Process Algorithm for Patients with Risk Factor for B 12 Deficiency* and/or Non-specific** or Specific Symptom of B 12 Deficiency

A few commenters stated that hospitals that contract with outside vendors or consultants to update their MRFs on an annual basis, do so at a cost of $10,000 to $30,000 per hospital and those without vendor support report needing 5 to 30 full-time-equivalents (FTEs) to update their MRFs on an annual basis

USA 101 (Suppl 1), 52285235 (2004)

Lyophilized GHK-Cu maintains potency for 18-24 months or longer when frozen

The body must convert Cyanocobalamin into Methylcobalamin to use it

Results are minimal and because its done using toxin, only lasts a couple of months